InsiderTrades

Form 4 for PGNY Progyny, Inc.

Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001179110-21-010610 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMI 2021-12-03 2021-12-01+ PGNY Payson Norman Dir S - Sale+OE $49.46 -16.7K 568.0K -3% -$824.1K
D 2021-12-03 2021-12-01 PGNY Payson Norman Dir M - OptEx $1.45 +225.0K 233.7K +2,601% +$326.2K
D 2021-12-03 2021-12-01 PGNY Payson Norman Dir M - OptEx $0.00 -225.0K 36.2K -86% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-01 S D 1,200 $50.68 566,796 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $51.12, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
2 Common Common Stockq 2021-12-01 S D 1,402 $51.54 565,394 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.17 to $52.155, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
3 Common Common Stock 2021-12-01 S D 1,398 $52.24 563,996 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.165 to $52.4, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
4 Common Common Stock 2021-12-02 S D 5,046 $48.47 558,950 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.89 to 48.87, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
5 Common Common Stock 2021-12-02 S D 2,984 $49.19 555,966 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.9 to $49.885, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
6 Common Common Stock 2021-12-02 S D 300 $50.26 555,666 I — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.2 to $50.33, inclusive.
7 Common Common Stock 2021-12-01 S D 2,097 $48.24 570,229 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.91 to $47.58, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
8 Common Common Stock 2021-12-01 M A 225,000 $1.45 233,652 D See footnote — — (F1) Adjusted due to rounding error. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
9 Common Common Stock 2021-12-01 S D 2,233 $49.42 567,996 I See footnote — — (F4) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (6), (7), (8), (9), (10), (11) and (12). (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.99 to $49.86, inclusive. (F5) The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
10 Derivative Stock Option (right to buy) 2021-12-01 M D 225,000 $0.00 36,223 D $1.45 · — to 2026-12-07 225,000 Common Stock (F1) Adjusted due to rounding error. (F14) One forty-eighth (1/48th) of the shares subject to the Option vested or shall vest each month commencing January 2, 2017, subject to the Reporting Person continuing to provide service through each such date.